M Zdunek Selected Research

Digoxin (Digitek)

7/2000

Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Zdunek Research Topics

Disease

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2001 - 01/2000
2	Neoplasms (Cancer) 01/2006 - 01/2001
1	Carcinoma (Carcinomatosis) 01/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2009
1	Coinfection 01/2006
1	Poisoning 07/2000
1	Renal Insufficiency (Renal Failure) 07/2000
1	Acute Kidney Injury (Acute Renal Failure) 07/2000
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2000

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2001 - 01/2000
2	ParaffinIBA 01/2009 - 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Etoposide (VP 16)FDA LinkGeneric 01/2001
1	Proteins (Proteins, Gene)FDA Link 01/2001
1	Messenger RNA (mRNA)IBA 01/2001
1	Digoxin (Digitek)FDA LinkGeneric 07/2000
1	Immunoglobulin FragmentsIBA 07/2000
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2001 - 01/2000
2	Aftercare (After-Treatment) 01/2000 - 01/2000
1	Vulvectomy 01/2006
1	Induction Chemotherapy 12/2001
1	Plasma Exchange 07/2000